Testing new drugs is a process. Here's how it begins. The process of testing and clearing new drugs for public use is a lengthy one. Once a drug has been developed and proven to be safe for animals, ...

Vigil Neuroscience reported positive Phase 1 trial results for VG-3927 and plans a Phase 2 trial in Q3 2025. Vigil Neuroscience, Inc. announced promising outcomes from a Phase 1 clinical trial of ...

INmune Bio Inc. has announced the completion of the third and highest dose cohort in the Phase I portion of its clinical trial for the NK cell therapy INKmune™, which is aimed at treating men with ...

The 2025 MLB All-Star Game is just a few short weeks away, with the baseball world set to converge on Truist Park in Atlanta for the annual exhibition of the game's best and brightest. Phase 1 of the ...